JP2023532290A5 - - Google Patents
Info
- Publication number
- JP2023532290A5 JP2023532290A5 JP2022580180A JP2022580180A JP2023532290A5 JP 2023532290 A5 JP2023532290 A5 JP 2023532290A5 JP 2022580180 A JP2022580180 A JP 2022580180A JP 2022580180 A JP2022580180 A JP 2022580180A JP 2023532290 A5 JP2023532290 A5 JP 2023532290A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- coronavirus
- peptide
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063044773P | 2020-06-26 | 2020-06-26 | |
| US63/044,773 | 2020-06-26 | ||
| US202063064836P | 2020-08-12 | 2020-08-12 | |
| US63/064,836 | 2020-08-12 | ||
| US202063124200P | 2020-12-11 | 2020-12-11 | |
| US63/124,200 | 2020-12-11 | ||
| US202163145200P | 2021-02-03 | 2021-02-03 | |
| US63/145,200 | 2021-02-03 | ||
| PCT/US2021/039134 WO2021263131A1 (en) | 2020-06-26 | 2021-06-25 | Compositions and methods for inducing an immune response against coronavirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532290A JP2023532290A (ja) | 2023-07-27 |
| JP2023532290A5 true JP2023532290A5 (enExample) | 2024-07-08 |
Family
ID=79281915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022580180A Pending JP2023532290A (ja) | 2020-06-26 | 2021-06-25 | コロナウイルスに対する免疫応答を誘導するための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230263882A1 (enExample) |
| EP (1) | EP4171574A4 (enExample) |
| JP (1) | JP2023532290A (enExample) |
| KR (1) | KR20230044404A (enExample) |
| AU (1) | AU2021294342A1 (enExample) |
| BR (1) | BR112022026580A2 (enExample) |
| CA (1) | CA3183735A1 (enExample) |
| MX (1) | MX2023000041A (enExample) |
| WO (1) | WO2021263131A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI884296B (zh) * | 2020-08-11 | 2025-05-21 | 美商碩騰服務公司 | 抗冠狀病毒疫苗 |
| EP4157344A2 (en) * | 2020-08-31 | 2023-04-05 | CureVac SE | Multivalent nucleic acid based coronavirus vaccines |
| WO2023114570A1 (en) * | 2021-12-19 | 2023-06-22 | Massachusetts Institute Of Technology | Compositions and methods for long-lasting germinal center responses to a priming immunization |
| WO2023159081A2 (en) * | 2022-02-15 | 2023-08-24 | Ohio State Innovation Foundation | Nanotechnology based intranasal vaccine for covid-19 |
| CN114752631B (zh) * | 2022-06-15 | 2022-09-02 | 中国人民解放军军事科学院军事医学研究院 | Rna及包含其的新型冠状病毒疫苗和制备方法 |
| WO2024226775A2 (en) * | 2023-04-26 | 2024-10-31 | Elicio Therapeutics, Inc. | Compositions containing polynucleotide and polypeptide amphiphiles and methods of use thereof |
| WO2025240477A1 (en) * | 2024-05-17 | 2025-11-20 | The Regents Of The University Of California | Methods and materials for enhancing delivery of nucleic acid to cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004108937A1 (en) * | 2003-06-04 | 2004-12-16 | Bioleaders Corporation | Cell surface expression vector of sars virus antigen and microorganisms transformed thereby |
| JP4691495B2 (ja) * | 2004-07-15 | 2011-06-01 | 一般財団法人化学及血清療法研究所 | コロナウイルススパイクｓ１融合蛋白及びその発現ベクター |
| JP6375289B2 (ja) * | 2012-04-05 | 2018-08-15 | マサチューセッツ インスティテュート オブ テクノロジー | 免疫刺激組成物およびその使用方法 |
| WO2015079952A1 (ja) * | 2013-11-29 | 2015-06-04 | テルモ株式会社 | アジュバント組成物およびこれを含むワクチン組成物、並びにこれらの製造方法 |
| MA52434A (fr) * | 2018-03-02 | 2021-01-06 | Elicio Therapeutics Inc | Amphiphiles cpg et leurs utilisations |
| BR112022015565A2 (pt) * | 2020-02-07 | 2022-09-27 | Modernatx Inc | Vacinas de domínio de mrna para sars-cov-2 |
-
2021
- 2021-06-25 CA CA3183735A patent/CA3183735A1/en active Pending
- 2021-06-25 JP JP2022580180A patent/JP2023532290A/ja active Pending
- 2021-06-25 MX MX2023000041A patent/MX2023000041A/es unknown
- 2021-06-25 WO PCT/US2021/039134 patent/WO2021263131A1/en not_active Ceased
- 2021-06-25 KR KR1020237002322A patent/KR20230044404A/ko active Pending
- 2021-06-25 US US18/012,343 patent/US20230263882A1/en active Pending
- 2021-06-25 BR BR112022026580A patent/BR112022026580A2/pt not_active Application Discontinuation
- 2021-06-25 EP EP21829804.0A patent/EP4171574A4/en active Pending
- 2021-06-25 AU AU2021294342A patent/AU2021294342A1/en not_active Abandoned